Efg Asset Management (North America) Corp. Veracyte, Inc. Transaction History
Efg Asset Management (North America) Corp.
- $705 Million
- Q4 2024
A detailed history of Efg Asset Management (North America) Corp. transactions in Veracyte, Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 206,227 shares of VCYT stock, worth $8.45 Million. This represents 1.16% of its overall portfolio holdings.
Number of Shares
206,227
Previous 204,254
0.97%
Holding current value
$8.45 Million
Previous $6.95 Million
17.5%
% of portfolio
1.16%
Previous 1.19%
Shares
13 transactions
Others Institutions Holding VCYT
# of Institutions
328Shares Held
81.9MCall Options Held
134KPut Options Held
13.3K-
Vanguard Group Inc Valley Forge, PA8.21MShares$336 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$319 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$270 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$172 Million1.46% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$167 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.93B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...